Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2005
11/03/2005DE102004017934A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005DE102004017932A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005DE102004017930A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005CA2565219A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005CA2563826A1 Treatment of cns disorders using cns target modulators
11/03/2005CA2563639A1 2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer~s disease
11/03/2005CA2562571A1 Novel androgens
11/03/2005CA2562417A1 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005CA2562377A1 Novel piperidine substituted diaminothiazoles
11/03/2005CA2562100A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005CA2560373A1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
11/03/2005CA2559688A1 Novel alkyne compounds with an mch-antagonistic action and medicaments comprising said compounds
11/03/2005CA2559237A1 Novel alkyne compounds having an mch-antagonistic effect and medicaments containing said compounds
11/03/2005CA2559021A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds
11/03/2005CA2558755A1 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds
11/02/2005EP1591444A1 CCR5 antagonists useful for treating aids
11/02/2005EP1591443A1 Pyrazole derivative
11/02/2005EP1590346A1 4- {'3-(sulfonylamino) phenyl! '1-(cyclymethyl) piperidin-4-ylidene! methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
11/02/2005EP1590344A2 Anti-cancer medicaments
11/02/2005EP1590342A1 Diazepanes derivatives useful as lfa inhibitors
11/02/2005EP1590341A1 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590339A2 Chemical compounds
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590336A2 Substituted pyrazoles, compositions containing such compounds and methods of use
11/02/2005EP1590334A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
11/02/2005EP1590329A1 N-aryl heteroaromatic products, compositions containing same and use thereof
11/02/2005EP1590327A1 Ccr8 inhibitors
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1590325A1 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1589968A2 Quaternary antimuscarinic compounds for the treatment of bladder diseases
11/02/2005EP1476164B1 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
11/02/2005EP1427719B1 4-alkyl-substitute thienyloxy-pyridines
11/02/2005EP1427415A4 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
11/02/2005EP1392679B1 Novel 1-amidomethylcarbonyl-piperidine derivatives, method for the production thereof and medicament containing said compounds
11/02/2005EP1377569B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
11/02/2005EP1311501B1 Antithrombotic agents
11/02/2005EP1263503B1 Use of cyanoquinolines for treating or inhibiting colonic polyps
11/02/2005EP1159261B1 Antizyme modulators and their use
11/02/2005EP1045833B1 2,3-substituted indole compounds as cox-2 inhibitors
11/02/2005EP1005493B1 Antiviral protease inhibitors
11/02/2005EP0929520B1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1692108A Pesticidal heterocycles
11/02/2005CN1692100A 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl]benzamide derivatives and their use for the treatment of pain spinal injuries or gastrointestinal disorders
11/02/2005CN1690051A Novel azoles having an insecticidal action
11/02/2005CN1225471C Compounds with growth hormone releasing properties
11/02/2005CN1225466C Sodium-hydrogen exchanger type 1 inhibitor (NHE-1)
11/02/2005CN1225465C Novel compounds
11/02/2005CN1225462C New piperazine and piperidine compounds
11/02/2005CN1225459C NItroxyderivatives having antiinflammatory, analgesic and antithrombotic activity
11/01/2005US6960667 Such as 1,1'-(1,2-ethanediyl)bis(3,4-diphenyl)-1H-pyrrole-2,5-dione; improved photostability
11/01/2005US6960636 Does not require solvent to provide viscosity for handling; low moisture uptake; for adhesives
11/01/2005US6960612 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960603 Emzyme inhibitors, a 4-pyridinyl-3-pyrazoles derivatives, treating animal having cancer, restenosis, psoriasis, endometriosis, atherosclerosis, ischemia, myocardial ischemic; a plant having yeast infection and viral infection
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960600 a triazole or amidazole compound containing oxy, hydroxy or aromatic rings; active on candidoses, cryptococcoses caused by Candida albicans; prevention of mycosic diseases in individuals with immunodeficiency.
11/01/2005US6960599 Dopamine D2 receptor and 5-HT1A antagonists; schizophrenia; cognitive activators; Alzheimer's disease; brain disorders; strokes; antiischemic agents; anxiolytic agents; obsessive compulsive disorder; eating, sleeping and sexual disorders
11/01/2005US6960591 Propane-1,3-dione derivative
11/01/2005US6960590 Orally active salts with tyrosine kinase activity
11/01/2005US6960589 Administering to a mammal suffering from sexual disorder a benzimidazole derivative containing piperazine or piperidine ring
11/01/2005US6960586 Having a steroid C17,20-lyase inhibitory activity; useful as prophylactic or therapeutic agent for prostate and breast cancers
11/01/2005US6960582 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes
11/01/2005US6960580 Kinase inhbitor; antiproliferative agents
11/01/2005US6960578 Glutamate receptor antagonists
11/01/2005US6960576 Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
11/01/2005US6960575 Thiazine derivatives
11/01/2005US6960572 Indolinones and uses thereof
10/2005
10/27/2005WO2005101838A2 Piperazinylpiperidine derivatives as chemokine receptor antagonists
10/27/2005WO2005100505A1 New organic luminescent element
10/27/2005WO2005100352A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005WO2005100349A2 Polycyclic pyridines as potassium ion channel modulators
10/27/2005WO2005100344A1 Inhibitors of akt activity
10/27/2005WO2005100343A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
10/27/2005WO2005100342A1 Pyridine inhibitors of erk2 and uses thereof
10/27/2005WO2005100341A1 2-aminopyridine derivative
10/27/2005WO2005100340A2 Polycyclic pyridines as potassium ion channel modulators
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2005100323A1 Process for preparing pyridazinone compounds
10/27/2005WO2005100322A1 Sulphur-linked imidazole compounds for the treament of hiv
10/27/2005WO2005100321A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
10/27/2005WO2005099711A1 Polycyclic pyrimidines as potassium ion channel modulators
10/27/2005WO2005099709A2 Bicyclic heterocycles useful as serine protease inhibitors
10/27/2005WO2005099707A1 17 beta-acetamide-4-azasteroids as androgen receptor modulators
10/27/2005WO2005074642A3 Chemical compounds
10/27/2005WO2005066154A3 Polymorphs of 1-cyclopropyl-6-fuoro-8-methoxy-7-(4-amino-3, 3-dimethylpiperidin-1-yl) -1, 4-dihydro-4-oxo-quinoline-3-carboxylic acid hydrochloride and mesalyte salts
10/27/2005WO2005061483A3 Modulators of peripheral 5-ht receptors
10/27/2005WO2005058824A3 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprote in b
10/27/2005WO2005044988A3 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
10/27/2005WO2005040338A3 Constrained alkaloid immunogens and antibodies and uses thereof
10/27/2005WO2004089903A9 Piperidine derivatives as renin inhibitors for the treatment of hypertension
10/27/2005WO2004058704A8 Quinazolinones as potassium channel modulators
10/27/2005WO2004048330A8 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
10/27/2005US20050240035 polymerase inhibitors such as -1-(5-Cyano-pyridin-2-yl)-3-(1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea, used as antiviral agents
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050240021 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators
10/27/2005US20050239870 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; aminoalkylamide, piperidine-, indole-, or pyrrole-amide derivatives; anticarcinogenic agents
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
1 ... 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 ... 1080